| Product Code: ETC7637201 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Personalized Cancer Medicine Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Personalized Cancer Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Personalized Cancer Medicine Market - Industry Life Cycle |
3.4 Ireland Personalized Cancer Medicine Market - Porter's Five Forces |
3.5 Ireland Personalized Cancer Medicine Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Ireland Personalized Cancer Medicine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Personalized Cancer Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Technological advancements in personalized medicine |
4.2.3 Growing investments in healthcare infrastructure and research |
4.2.4 Rising awareness about personalized cancer treatments |
4.3 Market Restraints |
4.3.1 High costs associated with personalized cancer medicine |
4.3.2 Regulatory challenges and approvals for personalized treatments |
4.3.3 Limited accessibility and affordability for certain patient segments |
4.3.4 Resistance from traditional healthcare systems towards adopting personalized approaches |
5 Ireland Personalized Cancer Medicine Market Trends |
6 Ireland Personalized Cancer Medicine Market, By Types |
6.1 Ireland Personalized Cancer Medicine Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Personalized Cancer Medicine Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Ireland Personalized Cancer Medicine Market Revenues & Volume, By Personalized Medicine Diagnostics, 2021- 2031F |
6.1.4 Ireland Personalized Cancer Medicine Market Revenues & Volume, By Personalized Medicine Therapeutics, 2021- 2031F |
6.2 Ireland Personalized Cancer Medicine Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Ireland Personalized Cancer Medicine Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.2.3 Ireland Personalized Cancer Medicine Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Personalized Cancer Medicine Market Import-Export Trade Statistics |
7.1 Ireland Personalized Cancer Medicine Market Export to Major Countries |
7.2 Ireland Personalized Cancer Medicine Market Imports from Major Countries |
8 Ireland Personalized Cancer Medicine Market Key Performance Indicators |
8.1 Percentage increase in adoption of personalized cancer treatments in Ireland |
8.2 Number of clinical trials and research studies focusing on personalized cancer medicine |
8.3 Patient satisfaction rates with personalized treatment plans |
8.4 Average wait times for accessing personalized cancer treatments |
8.5 Number of partnerships and collaborations between healthcare providers and personalized medicine companies |
9 Ireland Personalized Cancer Medicine Market - Opportunity Assessment |
9.1 Ireland Personalized Cancer Medicine Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Ireland Personalized Cancer Medicine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Personalized Cancer Medicine Market - Competitive Landscape |
10.1 Ireland Personalized Cancer Medicine Market Revenue Share, By Companies, 2024 |
10.2 Ireland Personalized Cancer Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here